Available Guidelines: ESMO Guidelines: Revision history

2 December 2025

• curprev 16:1916:19, 2 December 2025‎ Francine talk contribs‎ 4,767 bytes +48‎ No edit summary undo

28 August 2024

• curprev 09:5309:53, 28 August 2024‎ Victor talk contribs‎ 4,719 bytes +1‎ No edit summary undo

30 April 2024

• curprev 12:2112:21, 30 April 2024‎ Francine talk contribs‎ 4,718 bytes −17‎ No edit summary undo

29 April 2024

• curprev 19:4319:43, 29 April 2024‎ Francine talk contribs‎ 4,735 bytes +1‎ No edit summary undo
• curprev 19:4219:42, 29 April 2024‎ Francine talk contribs‎ 4,734 bytes +25‎ No edit summary undo

25 April 2024

• curprev 17:2817:28, 25 April 2024‎ Francine talk contribs‎ 4,709 bytes +1‎ No edit summary undo
• curprev 17:2717:27, 25 April 2024‎ Francine talk contribs‎ 4,708 bytes +117‎ No edit summary undo

16 June 2023

• curprev 17:5317:53, 16 June 2023‎ Francine talk contribs‎ 4,591 bytes +29‎ No edit summary undo

1 June 2023

• curprev 13:3513:35, 1 June 2023‎ Francine talk contribs‎ 4,562 bytes +1‎ No edit summary undo
• curprev 13:3413:34, 1 June 2023‎ Francine talk contribs‎ 4,561 bytes +4,561‎ Created page with "'''Breast Cancer''': * Metastatic Breast Cancer * Breast cancer in the COVID-19 era * Consensus Recommendations – Breast Cancer in Young Women (BCY5) * Early Breast Cancer * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes '''Cancers of Unknown Primary Site''': * Cancers of Unknown Primary Site '''Endocrine and Neuroendocrine Cancers''': * Adrenocortical Carcinomas and Malignant Phaeochromocytomas * Gastroenteropancreatic Neu..."